Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.
They do f.ck all communication, they do nothing to try and protect the sp & nothing to get IIs on board.
To add injury to an insult, the sales performance is below average this year, considering the spike in demand.
So yeah, try harder for the next agm.
PS Did somebody say they are already authorised to carry out a share buyback? Might be a good time for it.
Expected more than 20% tbf, but it looks like the company has thrown all of its resources on supplying the DHSC contract at the start of the year.
Let's see what our new Raffaello CEO will be able to do sales wise.
Poidster - do you know roughly how much promate is being used vs other tests? Is it a geographical breakdown? Up to each NHS trust to order the test they like? What's the overall system of deciding which test will be used by which testing centre?
As always, thank you for your inputs.